[PDF][PDF] Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost
J Goudevenos, A Pipilis, P Vardas - Hellenic J Cardiol, 2012 - hellenicjcardiol.org
Over the last fifty years, the stan-dard anticoagulant therapy for the prevention of stroke in
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …
[PDF][PDF] Novel Oral Anticoagulants in Atrial Fibrillation: Will the Benefit Outweigh the Cost?
J GOUDEVENOS, A PIPILIS, P VARDAS - Hellenic J Cardiol, 2012 - academia.edu
Over the last fifty years, the stan-dard anticoagulant therapy for the prevention of stroke in
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …
[引用][C] Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost?
J Goudevenos, A Pipilis… - Hellenic journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
[引用][C] Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost?
J Goudevenos, A Pipilis, P Vardas - Hellenic Journal of Cardiology …, 2012 - europepmc.org
Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost? - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[PDF][PDF] Novel Oral Anticoagulants in Atrial Fibrillation: Will the Benefit Outweigh the Cost?
J GOUDEVENOS, A PIPILIS, P VARDAS - Hellenic J Cardiol, 2012 - academia.edu
Over the last fifty years, the stan-dard anticoagulant therapy for the prevention of stroke in
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …
patients with atrial fibrillation (AF) has been vitamin K antagonists. Warfarin, their main …